ResMed EBIT 2010-2025 | RMD
ResMed annual and quarterly EBIT history from 2010 to 2025. EBIT can be defined as earnings before interest and taxes.
- ResMed EBIT for the quarter ending March 31, 2025 was $0.426B, a 13.8% increase year-over-year.
- ResMed EBIT for the twelve months ending March 31, 2025 was $1.612B, a 32.79% increase year-over-year.
- ResMed 2024 annual EBIT was $1.32B, a 16.61% increase from 2023.
- ResMed 2023 annual EBIT was $1.132B, a 13.15% increase from 2022.
- ResMed 2022 annual EBIT was $1B, a 10.69% increase from 2021.
| ResMed Annual EBIT (Millions of US $) |
|
|---|---|
| 2024 | $1,320 |
| 2023 | $1,132 |
| 2022 | $1,000 |
| 2021 | $904 |
| 2020 | $810 |
| 2019 | $579 |
| 2018 | $542 |
| 2017 | $426 |
| 2016 | $429 |
| 2015 | $409 |
| 2014 | $405 |
| 2013 | $355 |
| 2012 | $294 |
| 2011 | $267 |
| 2010 | $240 |
| 2009 | $190 |
| ResMed Quarterly EBIT (Millions of US $) |
|
|---|---|
| 2025-03-31 | $426 |
| 2024-12-31 | $417 |
| 2024-09-30 | $387 |
| 2024-06-30 | $381 |
| 2024-03-31 | $375 |
| 2023-12-31 | $275 |
| 2023-09-30 | $289 |
| 2023-06-30 | $275 |
| 2023-03-31 | $301 |
| 2022-12-31 | $280 |
| 2022-09-30 | $276 |
| 2022-06-30 | $255 |
| 2022-03-31 | $234 |
| 2021-12-31 | $249 |
| 2021-09-30 | $262 |
| 2021-06-30 | $242 |
| 2021-03-31 | $223 |
| 2020-12-31 | $222 |
| 2020-09-30 | $217 |
| 2020-06-30 | $223 |
| 2020-03-31 | $218 |
| 2019-12-31 | $198 |
| 2019-09-30 | $171 |
| 2019-06-30 | $121 |
| 2019-03-31 | $157 |
| 2018-12-31 | $157 |
| 2018-09-30 | $144 |
| 2018-06-30 | $147 |
| 2018-03-31 | $136 |
| 2017-12-31 | $146 |
| 2017-09-30 | $113 |
| 2017-06-30 | $127 |
| 2017-03-31 | $107 |
| 2016-12-31 | $97 |
| 2016-09-30 | $94 |
| 2016-06-30 | $119 |
| 2016-03-31 | $104 |
| 2015-12-31 | $108 |
| 2015-09-30 | $98 |
| 2015-06-30 | $100 |
| 2015-03-31 | $106 |
| 2014-12-31 | $109 |
| 2014-09-30 | $95 |
| 2014-06-30 | $98 |
| 2014-03-31 | $105 |
| 2013-12-31 | $105 |
| 2013-09-30 | $97 |
| 2013-06-30 | $86 |
| 2013-03-31 | $96 |
| 2012-12-31 | $92 |
| 2012-09-30 | $80 |
| 2012-06-30 | $90 |
| 2012-03-31 | $77 |
| 2011-12-31 | $67 |
| 2011-09-30 | $61 |
| 2011-06-30 | $67 |
| 2011-03-31 | $64 |
| 2010-12-31 | $70 |
| 2010-09-30 | $66 |
| 2010-06-30 | $69 |
| 2010-03-31 | $61 |
| 2009-12-31 | $58 |
| 2009-09-30 | $53 |
| 2009-06-30 | $58 |
| 2009-03-31 | $53 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $36.314B | $4.685B |
| ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.641B | 27.61 |
| Boston Scientific (BSX) | United States | $152.191B | 38.10 |
| Stryker (SYK) | United States | $148.126B | 30.97 |
| EssilorLuxottica (ESLOY) | France | $127.448B | 0.00 |
| Medtronic (MDT) | Ireland | $110.055B | 16.07 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.786B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.281B | 27.46 |
| GE HealthCare Technologies (GEHC) | United States | $33.934B | 16.11 |
| Agilent Technologies (A) | United States | $32.944B | 21.76 |
| Terumo (TRUMY) | Japan | $28.086B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $23.536B | 16.92 |
| Insulet (PODD) | United States | $22.286B | 87.48 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.433B | 12.48 |
| Baxter (BAX) | United States | $16.360B | 12.22 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.456B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.030B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.190B | 24.31 |
| Lantheus Holdings (LNTH) | United States | $5.502B | 13.88 |
| Prestige Consumer Healthcare (PBH) | United States | $4.350B | 19.43 |
| Perrigo (PRGO) | Ireland | $3.711B | 9.40 |
| ICU Medical (ICUI) | United States | $3.552B | 26.20 |
| Haemonetics (HAE) | United States | $3.528B | 15.37 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.144B | 26.13 |
| QuidelOrtho (QDEL) | United States | $2.531B | 17.41 |
| GN Store Nord (GNNDY) | Denmark | $2.188B | 18.12 |
| LeMaitre Vascular (LMAT) | United States | $1.863B | 41.65 |
| AtriCure (ATRC) | United States | $1.575B | 0.00 |
| Neogen (NEOG) | United States | $1.411B | 18.06 |
| AdaptHealth (AHCO) | United States | $1.229B | 12.48 |
| Kestra Medical Technologies (KMTS) | United States | $1.211B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.152B | 25.91 |
| BioLife Solutions (BLFS) | United States | $1.135B | 0.00 |
| InMode (INMD) | Israel | $1.043B | 9.55 |
| Phibro Animal Health (PAHC) | United States | $0.992B | 12.69 |
| Evolus (EOLS) | United States | $0.643B | 0.00 |
| CeriBell (CBLL) | United States | $0.620B | 0.00 |
| Owens & Minor (OMI) | United States | $0.552B | 4.58 |
| Curaleaf Holdings (CURLF) | Canada | $0.545B | 0.00 |
| Valneva SE (VALN) | France | $0.539B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.539B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.462B | 0.00 |
| Surmodics (SRDX) | United States | $0.387B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.357B | 0.00 |
| SNDL (SNDL) | Canada | $0.347B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.325B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.310B | 11.39 |
| Sanara MedTech (SMTI) | United States | $0.305B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.284B | 50.60 |
| Canopy Growth (CGC) | Canada | $0.268B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.261B | 0.00 |
| Cerus (CERS) | United States | $0.258B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.257B | 21.70 |
| ZimVie (ZIMV) | United States | $0.248B | 11.28 |
| Verano Holdings (VRNOF) | United States | $0.248B | 0.00 |
| Quanterix (QTRX) | United States | $0.222B | 0.00 |
| Omeros (OMER) | United States | $0.221B | 0.00 |
| Biote (BTMD) | United States | $0.218B | 6.14 |
| OraSure Technologies (OSUR) | United States | $0.200B | 0.00 |
| High Tide (HITI) | Canada | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.177B | 14.29 |
| Organigram Global (OGI) | Canada | $0.171B | 0.00 |
| Brainsway (BWAY) | Israel | $0.167B | 51.94 |
| TriSalus Life Sciences (TLSI) | United States | $0.165B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.145B | 17.82 |
| Jin Medical (ZJYL) | China | $0.141B | 0.00 |
| Exagen (XGN) | United States | $0.123B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.107B | 0.00 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| Agape ATP (ATPC) | $0.083B | 0.00 | |
| Fonar (FONR) | United States | $0.077B | 10.76 |
| Veru (VERU) | United States | $0.076B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.070B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Zynex (ZYXI) | United States | $0.065B | 0.00 |
| United Health Products (UEEC) | United States | $0.061B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.054B | 0.00 |
| ImmuCell (ICCC) | United States | $0.047B | 0.00 |
| Apyx Medical (APYX) | United States | $0.042B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.10 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.019B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |